CXCL8 and colorectal cancer: However, our former studies were shown that simvastatin (used to decrease the high level of blood cholesterol) although exhibits pleiotropic effects on carcinogenesis, inhibits the release of IL-8 and IL-6 from colorectal cell lines and decreases serum IL-6 level in patients with advanced colorectal cancer (34).